Sun-hee Leem
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
RETRACTED: Jeong et al. Protective Effects of Fermented Oyster Extract Against RANKL-Induced Osteoclastogenesis Through Scavenging ROS Generation in RAW 264.7 Cells. Int. J. Mol. Sci. 2019, 20, 1439.
Journal: International journal of molecular sciences
Published: June 04, 2026
Therapy-Driven Molecular Evolution of Bladder Cancer: Roles of Cellular Plasticity and Tumor Microenvironment.
Journal: International journal of molecular sciences
Published: March 25, 2026
Compound K Mitigates PM 2.5-induced Premature Senescence in ARPE-19 Human Retinal Pigment Epithelial Cells through Activation of the Nrf2/HO-1 Pathway.
Journal: Biomedical and environmental sciences : BES
Published: February 13, 2026
Combination Therapy with Betulinic Acid and TRAIL Increases ROS-Dependent Cytotoxicity and Inhibits PI3K/Akt Signaling in Human Bladder Cancer Cells.
Journal: Biomolecules & therapeutics
Published: February 04, 2026
Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets.
Journal: Genes & genomics
Published: October 05, 2025
Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer.
Journal: Clinical and translational medicine
Published: September 22, 2025
Pluviatolide Attenuates Type I Hypersensitivity through Regulation of Mast Cell Activation.
Journal: Biomolecules & therapeutics
Published: August 26, 2025
Emerging technologies and clinical translation of urine-based liquid biopsy in urological cancers.
Journal: Genes & genomics
Published: August 05, 2025
Erratum to "Morroniside Protects C2C12 Myoblasts from Oxidative Damage Caused by ROS-mediated Mitochondrial Damage and Induction of Endoplasmic Reticulum Stress" [Biomol Ther 32(3), 349-360 (2024)].
Journal: Biomolecules & therapeutics
Published: April 25, 2025
Erratum to 'Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial' [Clin Mol Hepatol 2024;30:807-823].
Journal: Clinical and molecular hepatology
Published: February 27, 2025
Particulate matter 2.5 stimulates pyroptosis and necroptosis via the p38 MAPK/Akt/NF-κB signaling pathway in human corneal epithelial cells.
Journal: Toxicology
Published: January 17, 2025
Last Updated: 09/26/2026